Management may provide some clarity on revenue potential of KARXT drug in concal. Karxt drug is just a feather in the cap and since it is claimed to be a block buster drug, there will be lot of recognition for Neuland in Big pharma and Company may get lot of new deals. Over a period of 2 to 3 years we may see significant increase in number project molecules in which Neuland will be working. As discussed earlier in this forum, the nature of business is lumpy, however ever year the base will increase as evident from last several years.
Disclosure : Invested and adding in SIP.
| Subscribe To Our Free Newsletter |
